EXTRAWELL PHARMACEUTICAL HOLDINGS LIMITED

Other languages Extrawell Pharmaceutical Holdings Limited

Equities

858 BMG3285Q1134

Market Closed - Hong Kong S.E. Other stock markets 01:38:32 29/05/2024 pm IST			5-day change	1st Jan Change
0.041 ^HKD	0.00%		-8.89%	+20.59%

2023	Extrawell Pharmaceutical Swings to Fiscal H1 Loss on Fair Value Losses	MT
2023	Extrawell Pharmaceutical Holdings Limited Reports Earnings Results for the Half Year Ended September 30, 2023	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Extrawell Pharmaceutical Swings to Fiscal H1 Loss on Fair Value Losses	30/11
Extrawell Pharmaceutical Holdings Limited Reports Earnings Results for the Half Year Ended September 30, 2023	29/11
Extrawell Pharmaceutical Holdings Forecasts Swing to Loss in Fiscal H1; Shares Fall 3%	13/11
Extrawell Pharmaceutical Holdings Limited Provides Unaudited Consolidated Earnings Guidance for the Six Months Ended 30 September 2023	10/11
Extrawell Pharmaceutical's Fiscal Year 2023 Attributable Profit Falls	30/23/30
Extrawell Pharmaceutical Holdings Limited Reports Earnings Results for the Full Year Ended March 31, 2023	29/23/29
Extrawell Pharmaceutical Unit Completes Share Buyback Deal	20/23/20
Extrawell Pharmaceutical to Swing to Loss in FY23	16/23/16
Extrawell Pharmaceutical Holdings Limited Provides Unaudited Consolidated Earnings Guidance for the Year Ended 31 March 2023	16/23/16
Extrawell Pharmaceutical Holdings Limited Appoints Guo Yi as an INED of the Company, and A Member of Each of the Audit Committee, Remuneration Committee and Nomination Committee of the Board with Effect from 14 April 2023	14/23/14
Extrawell Pharmaceutical Holdings Limited Announces Demise of Mr. Xue Jing Lun, Independent Non-Executive Director, and A Member of Each of the Audit Committee, Remuneration Committee and Nomination Committee	07/22/07
Extrawell Pharmaceutical's Profit for Six Months Through September Nearly Halves	30/22/30
Extrawell Pharmaceutical Holdings Limited Reports Earnings Results for the Half Year Ended September 30, 2022	29/22/29
Extrawell Pharmaceutical Forecasts Decline in Fiscal H1 Profit	17/22/17
Extrawell Pharmaceutical Holdings Limited Provides Earnings Guidance for the Six Months Ended 30 September 2022	17/22/17
Extrawell Pharmaceutical Holdings Limited Announces Management Changes	30/22/30
Extrawell Pharmaceutical Holdings Swings to Profitability in FY22	01/22/01
Extrawell Pharmaceutical Holdings Limited Reports Earnings Results for the Full Year Ended March 31, 2022	29/22/29
Extrawell Pharma Sees Profit Surge in FY22	20/22/20
Extrawell Pharmaceutical Holdings Limited Provides Consolidated Earnings Guidance for the Year Ended March 31, 2022	17/22/17

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Extrawell Pharmaceutical Holdings Limited

Equities

858

BMG3285Q1134

Other languages

Filters